Clinical Failures Could be Reduced Through the use of Human Tissue
News Mar 28, 2006
Asterand plc has recognised the benefits of utilising human tissue during the drug discovery and development process to help provide better, safer medicines to treat human disease, and is working with many of the leading pharmaceutical and biotechnology companies to support their drug discovery and development programs.
"The value of using human tissue during drug discovery and drug development within the pharmaceutical industry is becoming increasingly important," says Randal Charlton Chief Executive at Asterand.
"There is a compelling need to reduce the unacceptable failure rate associated with converting drug development candidates into safe, effective medicines."
"While no amount of testing on human tissue can accurately predict clinical success, identifying early where a drug target is expressed in the human body and how the functional response to a drug compares to that in animals can provide a useful insight, helping to highlight potential failures before entering the clinic."
More than 60 years after the drug thalidomide caused birth defects in thousands of children whose mothers took the drug while pregnant, scientists have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?READ MORE
Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent painful swellings of the skin and mucous membranes. A new drug has been developed to help prevent attacks of hereditary angioedema. It has now been investigated in an international study performed at over 26 university facilities in Europe, Canada and Australia.READ MORE